{"id":31338,"date":"2014-09-17T07:55:49","date_gmt":"2014-09-17T11:55:49","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31338"},"modified":"2014-09-17T07:55:49","modified_gmt":"2014-09-17T11:55:49","slug":"siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338","title":{"rendered":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/17\/2014 (wallstreetpr) \u2013 Pharmaceutical company, <strong>SIGA Technologies, Inc. (NASDAQ:SIGA)<\/strong> disclosed that it has preferred the route of Chapter 11 bankruptcy protection to not only preserve itself, but also assure its capability to satisfy its commitment to supply antiviral smallpox drug, Tecovirimat.<\/p>\n<p style=\"text-align: justify;\"><strong>Bankruptcy Protection<\/strong><\/p>\n<p style=\"text-align: justify;\">The company said that it has voluntarily filed a petition for relief before the U.S. Bankruptcy Court of the New York Southern District as per the Chapter 11 of the U.S. Bankruptcy Code, its press <a href=\"http:\/\/finance.yahoo.com\/news\/siga-technologies-inc-files-chapter-104700471.html\" target=\"_blank\">statement<\/a> revealed. The company also said that it has initiated the process to ensure its commitment to the Strategic National Stockpile in the U.S. as per the Project BioShield Act of 2004 so as to supply antiviral smallpox drug.<\/p>\n<p style=\"text-align: justify;\">SIGA Technologies, Inc. (NASDAQ:SIGA) plans to function as a going concern under the Chapter 11 period for the benefit of every economic stakeholder, as well as, the U.S. government. The filing would also ensure that there would not be any issue in supplying its Tecovirimat drug following its agreement with the Biomedical Advanced Research and Development Authority or BARDA. Besides, it would also follow its meritorious appeal of pending proceedings in Delaware Chancery Court.<\/p>\n<p style=\"text-align: justify;\"><strong>Background Of Case<\/strong><\/p>\n<p style=\"text-align: justify;\">The company indicated earlier that the Delaware Chancery Court has issued an unfavorable order in the litigation filed by PharmAthene, Inc. in 2006. Among other things, the court has ruled that PharmAthene was entitled to damages of a lump sum with interest and fees based on the purchases of smallpox drug made by the U.S. government that alleged to have been expected as of December 2006.<\/p>\n<p style=\"text-align: justify;\">Though the court has not disclosed the amount of damages to be slapped against SIGA Technologies, the company believes it could be a substantial amount and that enforcement of such a judgment would jeopardize its ability and viability to produce and deliver the smallpox drug.<\/p>\n<p style=\"text-align: justify;\"><strong>Management Comments<\/strong><\/p>\n<p style=\"text-align: justify;\">SIGA Technologies, Inc. (NASDAQ:SIGA) Chairman and Chief Executive Officer, Eric Rose, said that the company has enough liquidity to conduct its operations apart from satisfying all its contractual commitments. It would pursue its appellate rights in the court.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/17\/2014 (wallstreetpr) \u2013 Pharmaceutical company, SIGA Technologies, Inc. (NASDAQ:SIGA) disclosed that it has preferred the route of Chapter 11 bankruptcy protection to not [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":31339,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[9259,7825,7824,7823],"stock_ticker":[],"class_list":["post-31338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-eric-rose","tag-nasdaqsiga","tag-siga-technologies-inc","tag-siga-technologies-inc-nasdaqsiga","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/17\/2014 (wallstreetpr) \u2013 Pharmaceutical company, SIGA Technologies, Inc. (NASDAQ:SIGA) disclosed that it has preferred the route of Chapter 11 bankruptcy protection to not [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-17T11:55:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"89\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug\",\"datePublished\":\"2014-09-17T11:55:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\"},\"wordCount\":364,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg\",\"keywords\":[\"Eric Rose\",\"NASDAQ:SIGA\",\"SIGA Technologies Inc.\",\"SIGA Technologies Inc. (NASDAQ:SIGA)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\",\"name\":\"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg\",\"datePublished\":\"2014-09-17T11:55:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg\",\"width\":275,\"height\":89},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338","og_locale":"en_US","og_type":"article","og_title":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR","og_description":"Boston, MA 09\/17\/2014 (wallstreetpr) \u2013 Pharmaceutical company, SIGA Technologies, Inc. (NASDAQ:SIGA) disclosed that it has preferred the route of Chapter 11 bankruptcy protection to not [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-17T11:55:49+00:00","og_image":[{"width":275,"height":89,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug","datePublished":"2014-09-17T11:55:49+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338"},"wordCount":364,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg","keywords":["Eric Rose","NASDAQ:SIGA","SIGA Technologies Inc.","SIGA Technologies Inc. (NASDAQ:SIGA)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338","url":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338","name":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg","datePublished":"2014-09-17T11:55:49+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/SIGA.jpg","width":275,"height":89},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/siga-technologies-inc-nasdaqsiga-commences-chapter-11-case-to-assure-its-commitment-to-supply-antiviral-smallpox-drug-31338#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31338"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31338\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/31339"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31338"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}